Global Amniotic Membrane Market, By Product (Dehydrated Amniotic Membrane, Cryopreserved Amniotic Membrane and Others), Application (Surgical Wounds, Ophthalmology and Others), End-User (Hospitals, Ambulatory Surgical Centers, Research Institutes and Academic Institutes and Specialty Clinics) – Industry Trends and Forecast to 2029
Market Analysis and Size
The amniotic membrane is the deepest layer of foetal membrane that is taken from a woman's placenta and used as a transplant material for cases such as severe trauma wounds, burnt skin, chronic wounds, and others. Due to technical advancements in the development of cost-effective therapeutics, the amniotic membrane market is likely to rise significantly during the forecast period 2022 to 2029. The market is expected to develop due to an increase in amniotic membrane transplantation, increased knowledge and education about the benefits of amniotic membrane transplantation, and the growing geriatric population.
Data Bridge Market Research analyses that the amniotic membrane market which was USD 1326.29 million in 2021, would rocket up to USD 3123.20 million by 2029, and is expected to undergo a CAGR of 11.30% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Dehydrated Amniotic Membrane, Cryopreserved Amniotic Membrane and Others), Application (Surgical Wounds, Ophthalmology and Others), End-User (Hospitals, Ambulatory Surgical Centers, Research Institutes and Academic Institutes and Specialty Clinics)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Tissue-Tech Inc. (U.S), Applied Biologics (U.S), LifeLike BioTissue (U.S), Celularity Inc, (U.S), Labtician Ophthalmics Inc. (Canada), Smith+Nephew (U.K), Stryker (U.S), WWW.SURGILOGIX.COM. (U.S), Integra LifeSciences (U.S), MiMedx (U.S), Skye Biologics Holdings LLC (U.S), Amniox Medical Inc (U.S), Human Regenerative Technologies LLC (U.S), Katena Products Inc (U.S), and Amnio Technology, LLC (U.S)
|
|
Market Opportunities
|
|
Market Definition
The amniotic membrane, also called the amnion, is the placenta's innermost layer. A thick foundation membrane and an avascular stromal matrix make up this structure. In different surgical specialisations, amniotic membrane transplantation has been used as a graft or as a dressing. In pterygium surgery, amniotic membrane tissue is transplanted after the aberrant tissue on the corneal side is peeled away without injuring the underlying corneal tissue.
Amniotic Membrane Market Dynamics
Drivers
- High incidence of burn wound cases
According to WHO, the majority of burn incidents occur in low- and middle-income countries, with over two-thirds happening in Africa and Southeast-Asia. Because burn wounds are so common, demand for wound care biologics such as amniotic membranes has skyrocketed. In India, one million people suffer from mild to severe burns each year (Source: WHO). Burns are also common in other Southeast Asian nations like Bangladesh and Nepal. The amniotic membrane burn therapy market is growing because it is effective in treating severe burn wounds.
- Rising craze to look flawless
Physical beauty has become one of the most important components of one's personality, and maintaining a faultless appearance is one of today's most popular trends. Amniotic tissues aid in the healing of wounds and burns. In recent years, Indians have embraced a high number of ophthalmology and cosmetic surgical treatments, which is likely to boost the expansion of amniotic membrane product suppliers in the country. Due to an increase in amniotic dry eye therapy, India's market is predicted to grow by double digits. Amniotic membranes are often used as a biological bandage to heal or replace injured eye tissues during eye procedures. The expanding popularity of dry eye amniotic membrane therapy, increased awareness among the general public, increasing amniotic membrane application, and growing popularity of skin care treatments are all likely to boost demand for amniotic goods in the country over the forecast period.
- Dry eye amniotic membrane treatment largely popular in the U.S.
The United States is likely to provide a large amount of revenue, since the country's chronic wound industry offers enormous opportunities for amniotic membrane suppliers. Because of the widespread use of amniotic membrane therapy for dry eye surface concerns has been included in ocular treatments. As a result of the growing number of ophthalmic surgeries performed in the United States as a result of the ageing population, the entire market is expanding significantly.
Opportunities
- Amniotic tissues and amniotic membrane fluid-promising treatment methods
The global amniotic membrane market is expected to be driven by the ageing population, expansion of amniotic membrane transplant indications, increased research and development
(R&D) investments in AMT by key players, increased focus on amniotic tissues cell and stem cell research, unmet clinical needs, regulatory harmonisation, and other factors.
Amniotic tissues and amniotic membrane fluid can be used to treat chronic plantar fasciosis and achilles tendinosis. Amniotic tissues can be used as a skin graft without having to worry about tissue typing or matching the donor to the receiver. As a result, amniotic membranes and amniotic membrane fluid could be used in new allografts and stem cell therapies for degenerative diseases. The ophthalmology market is predicted to increase gradually in the next years, primarily to the increasing use of tissue-based products in ocular treatments due to their speedy recovery properties, such as lowering inflammation and improving healing.
Restraints/Challenges
However, in the forecast period 2022 to 2029, limits on the usage of amniotic membranes and strict government regulations may impede the growth of the Europe amniotic membrane market. AM is now being researched for application in the treatment of cancer, lung injury, and other internal organ damage. Despite the positive results of lung damage treatment, the use of this treatment on patients is still up in the air. Because of the limited use of AM on skin tissues and some external organs, it has come to a halt in other therapies, and more study is undertaken. As a result, it is the only roadblock to AM's usage in medical treatment of chronic disorders in humans.
This amniotic membrane market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the amniotic membrane market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Amniotic Membrane Market
The COVID-19 outbreak had a negative influence on the amniotic goods industry in 2020 due to widespread lockdowns, refused wound care treatments, and cancelled or postponed elective surgeries. Elective operations were rejected (cancelled/postponed) so that scarce capacities and resources (such as hospital beds and patient care professionals) may be allocated or redirected to COVID-19 patient care. Several countries also implemented lockdowns and curfews to combat the rising number of COVID-19 cases. Lockdowns prevented patients from visiting hospitals, outpatient clinics, or clinics. This temporary stoppage of freefone healthcare services is expected to delay the market for amniotic goods. However, demand for amniotic products is expected to rise dramatically in the coming years.
Recent Development
- According to the Europe Transport Safety Council, the number of road deaths per million people in the European Union was 42 in 2020.
- In April 2021, SurgiLogix will debut their SXDBMTM Fiber allograft, which is made completely of demineralized cortical bone and does not require a carrier. When 100 percent demineralized cortical bone is hydrated with any bioactive ingredient, it creates a malleable fibrous structure that can be utilised to fix bony cavities or gaps. It absorbs blood, BMA, or PRP fast and forms a superior osteoconductive scaffold with increased osteoinductive potential.
Global Amniotic Membrane Market Scope
The amniotic membrane market is segmented on the basis of type, product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Cryopreserved
- Lyophilized
Application
- Surgical Wounds
- Ophthalmology
- Others
End-User
- Hospitals
- Specialized Clinics
- Ambulatory Surgical Centres
- Academic Research Centres
Amniotic Membrane Market Regional Analysis/Insights
The amniotic membrane market is analysed and market size insights and trends are provided by country, type, product, application and end-user as referenced above.
The countries covered in the amniotic membrane market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominating the market due to increased focus on alternative technologies and the adoption of modern technologies are predictable to drive market expansion in this area throughout the forecast period 2022 to 2029.
Asia-Pacific is anticipated to grow at a significant CAGR over the forecast period. The majority of the countries in this region are growing economically, with rising disposable income and several global corporations have made significant investments in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The amniotic membrane market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for amniotic membrane market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the amniotic membrane market. The data is available for historic period 2010-2020.
Competitive Landscape and Amniotic Membrane Market Share Analysis
The amniotic membrane market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to amniotic membrane market.
Some of the major players operating in the amniotic membrane market are:
- Tissue-Tech Inc. (U.S)
- Applied Biologics (U.S)
- LifeLike BioTissue (U.S)
- Celularity Inc, (U.S)
- Labtician Ophthalmics Inc. (Canada)
- Smith+Nephew (U.K)
- Stryker (U.S)
- WWW.SURGILOGIX.COM. (U.S)
- Integra LifeSciences (U.S)
- MiMedx (U.S)
- Skye Biologics Holdings LLC (U.S)
- Amniox Medical Inc (U.S)
- Human Regenerative Technologies LLC (U.S)
- Katena Products Inc (U.S)
- Amnio Technology, LLC (U.S)
SKU-